President Jokowi Asks For Booster Vaccinations Outside Java-Bali To Be Continuously Improved

JAKARTA - President Joko Widodo asked his staff to continue to increase the injection of booster vaccines to ward off COVID-19 outside Java and Bali.

"Mr. President also gave directions that the follow-up dose or booster outside Java should be increased now, nationally, the third dose is 2.3 percent and outside Java-Bali by 1.6 percent," said Coordinating Minister for Economic Affairs Airlangga Hartarto who is also the coordinator of PPKM abroad. Java-Bali after a limited online meeting chaired by President Jokowi as reported by Antara, Monday, January 31.

Airlangga said COVID-19 vaccination outside Java-Bali will continue to be increased so that it can be balanced with vaccinations in Java-Bali and can effectively prevent the spread of COVID-19.

Furthermore, he conveyed that there was a trend of increasing daily cases outside Java-Bali, reaching 499 daily cases.

"Cases outside Java-Bali show that daily cases have indeed increased to 499, with local transmission of 496, and cases based on PPLN (Overseas Travel Actors) about 3 people, and the death rate as of January 30 was 2 people," he said. .

That way, on January 30, 2022, the number of active cases of COVID-19 outside Java-Bali reached 3,326 cases out of 61,713 active cases nationwide or 5.4 percent.

"We must also be vigilant because we can see from the case of effective reproduction (Rt) of COVID-19 that in Sumatra it rose to 1.02, in Kalimantan to 1.01, Maluku 1.08, Papua Province 1.05, Nusa Tenggara 1.03 and Sulawesi 1," he said.

Based on the limited PPKM evaluation meeting, the government, said Airlangga, decided to extend PPKM outside Java-Bali on February 1-14 2022.

"If we look ahead outside Java-Bali there will be an extension, namely February 1-14 based on the level of the pandemic assessment, whether it is related to community transmission or the level of case transmission, the death rate, as well as hospitalization, as well as the response related to testing, tracing, and treatment," said Airlangga.